Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112479 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Lingjie Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Wanli University, Ningbo 315100, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Drugs, Chinese Herbal, Disease Models, Animal, Dinitrochlorobenzene. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Shen chan decoction (SCD) as a significant Traditional Chinese medicine (TCM) to treat atopic dermatitis (AD), but its mechanism of action has not been clarified, so we started the present study, first possible effects of SCD on AD were predicted using network pharmacology. Next, dinitrochlorobenzene was used to establish a mouse model of AD. After successful modelling, the SCD were administered intragastrically to treat the mice. Eventually, the KEGG pathway enrichment analysis indicated that SCD improved AD mainly through effects on inflammation and the gut microbiota. The experimental findings revealed that SCD treatment attenuated AD symptoms and downregulate the characteristic immune factors, namely IL-4, IL-6 and IgE. Moreover, it promoted a balance between Th1/Th2 cells. Furthermore, the itch signaling pathways involving H1R/PAR-2/TRPV1 were inhibited. The 16S rRNA sequencing results indicated that SCD administration influenced the Firmicutes/Bacteroidetes ratio at the phylum level by augmenting the relative proportions of Lactobacillaceae and Muribaculaceae at the family and genus levels, while decreasing the abundances of Lactococcus and Ruminococcus. These findings suggest that internal administration of SCD is an effective therapeutic approach for AD. We suggest that SCD may be an alternative therapy for the treatment of AD.Additionally, it could offer valuable insights into the pathogenesis of AD and the development of innovative therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Wanli University, Ningbo 315100, China.
- Ningbo Hospital of Traditional Chinese Medicine, Ningbo 315010, China.
- Zhejiang Pharmaceutical University, Ningbo 315100, China.
- Wenzhou Medical University, Wenzhou 325035, China.
- Zhejiang Wanli University, Ningbo 315100, China; Ningbo First Hospital, Ningbo 315010, China.
- Zhejiang Wanli University, Ningbo 315100, China; Zhejiang Pharmaceutical University, Ningbo 315100, China; Wenzhou Medical University, Wenzhou 325035, China. Electronic address: pharmhawk@126.com.
Zitieren
APA
Zhang, L., Chen, N., Liao, Y., Kong, Y., Yang, X., Zhan, M., Xu, W., Wang, Y., Zhu, S., & Hu, Y. (2024). Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112479
Vancouver
Zhang L, Chen N, Liao Y, Kong Y, Yang X, Zhan M, et al. Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112479
BibTeX
@article{Zhang2024,
author = {Zhang, Lingjie and Chen, Ninggang and Liao, Yi and Kong, Yun and Yang, Xiaoyue and Zhan, Mengting and Xu, Weiyi and Wang, Yan and Zhu, Suyan and Hu, Ying},
title = {Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112479}
}
EUVIMED